Accessibility Menu
 
Stella Diagnostics logo

Stella Diagnostics

(OTC) SLDX

Current Price$0.01
Market Cap$4.22M
Since IPO (2008)-100%
5 Year-99%
1 Year-71%
1 Month-13%

Stella Diagnostics Financials at a Glance

Market Cap

$4.22M

Revenue (TTM)

$1.78M

Net Income (TTM)

$4.06M

EPS (TTM)

$-0.01

P/E Ratio

-1.17

Dividend

$0.00

Beta (Volatility)

0.57 (Low)

Price

$0.01

Volume

5,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.05

SLDX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Stella Diagnostics

Industry

Healthcare Providers and Services

Employees

3

CEO

David Seaburg

Headquarters

Salt Lake City, UT 84104, US

SLDX Financials

Key Financial Metrics (TTM)

Gross Margin

-40%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

0%

Return on Capital

13%

Return on Assets

-24%

Earnings Yield

-85.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.22M

Shares Outstanding

301.50M

Volume

5.00K

Avg. Volume

86.635

Financials (TTM)

Gross Profit

$660.29K

Operating Income

$3.45M

EBITDA

$3.45M

Operating Cash Flow

$1.30M

Capital Expenditure

$0.00

Free Cash Flow

$1.30M

Cash & ST Invst.

$58.01K

Total Debt

$12.48M

Stella Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$491.54K

N/A

Gross Profit

$83.54K

N/A

Gross Margin

-16.99%

N/A

Market Cap

$4.22M

N/A

Market Cap/Employee

$2.11M

N/A

Employees

2

N/A

Net Income

$1.60M

-594.8%

EBITDA

$1.55M

-572.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$12.42M

-87.2%

Accounts Receivable

$10.22K

+0.0%

Inventory

$0.00

N/A

Long Term Debt

$5.18K

-92.1%

Short Term Debt

$12.48M

+89.7%

Return on Assets

-23.54%

N/A

Return on Invested Capital

13.06%

N/A

Free Cash Flow

$425.54K

-166.7%

Operating Cash Flow

$425.54K

-166.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TDSGFTelo Genomics Corp.
$0.04+0.00%
CNGGFCann Group Limited
$0.00+0.00%
DOGPDogecoin Cash, Inc.
$0.01+0.75%
TBRIFTherma Bright Inc.
$0.03+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About SLDX

What is the current price of Stella Diagnostics?

Stella Diagnostics is trading at $0.01 per share.

What is the 52-week range for Stella Diagnostics?

Over the past 52 weeks, Stella Diagnostics has traded between $0.01 and $0.05.

How much debt does Stella Diagnostics have?

As of the most recent reporting period, Stella Diagnostics reported total debt of $12.48M.

How much cash does Stella Diagnostics have on hand?

Stella Diagnostics reported $58,007 in cash and cash equivalents in its most recent financial results.

What is Stella Diagnostics’s dividend yield?

Stella Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.